TTK Healthcare Peer Comparison
NSE: TTKHLTCARE | BSE: 507747
₹918.75
₹4.50
(0.49%)
As on 03-Nov-2026 10:27IST
Market cap
₹1,291 Cr
Revenue (TTM)
₹918 Cr
P/E Ratio
4.7
P/B Ratio
1
Div. Yield
1.1 %
Edit
| TTK Healthcare | Acutaas Chemicals | Piramal Pharma | Wockhardt | Granules India | |
|---|---|---|---|---|---|
Market cap (₹ Cr) |
1,291 | 31,822 | 31,912 | 30,750 | 22,356 |
Revenue (₹ Cr) |
918 | 1,593 | 9,779 | 3,751 | 5,895 |
Net Profit (₹ Cr) |
276.54 | 438.64 | -270.51 | 405.00 | 713.58 |
Net Margin (%) |
27.96 | 27.16 | -2.71 | 10.48 | 12.07 |
RoE (%) |
5.94 | 25.02 | -2.55 | 7.91 | 12.04 |
Price to Earnings |
4.67 | 72.46 | -- | 75.00 | 31.33 |
Price-To-Book |
0.96 | 17.13 | 3.92 | 5.96 | 3.40 |
Income Statement (₹ Cr)
| TTK Healthcare | Acutaas Chemicals | Piramal Pharma | Wockhardt | Granules India | |
|---|---|---|---|---|---|
|
Operating Revenue
|
918.23 | 1,592.52 | 9,778.62 | 3,751.00 | 5,895.30 |
|
Total Income
|
988.96 | 1,615.23 | 9,993.26 | 3,863.00 | 5,913.38 |
|
Total Expenditure
|
881.58 | 969.32 | 8,578.44 | 2,984.00 | 4,558.61 |
|
EBITDA
|
36.64 | 623.20 | 1,200.18 | 767.00 | 1,336.69 |
|
Depreciation
|
8.67 | 41.96 | 887.82 | 228.00 | 318.79 |
|
EBIT
|
27.98 | 581.24 | 312.36 | 539.00 | 1,017.90 |
|
Interest
|
2.44 | 4.21 | 347.94 | 218.00 | 103.48 |
|
Other Income
|
70.74 | 22.71 | 214.64 | 112.00 | 18.09 |
|
Exceptional Items
|
244.13 | 0.00 | -216.88 | 12.00 | 15.92 |
|
Profit before Tax
|
340.40 | 599.74 | -37.82 | 445.00 | 948.42 |
|
Provision for Tax
|
63.86 | 161.10 | 232.69 | 40.00 | 234.84 |
|
Profit after Tax
|
276.54 | 438.64 | -270.51 | 405.00 | 713.58 |
Liabilities (₹ Cr)
| TTK Healthcare | Acutaas Chemicals | Piramal Pharma | Wockhardt | Granules India | |
|---|---|---|---|---|---|
|
Shareholder's Funds
|
1,346.54 | 1,857.45 | 8,142.24 | 5,158.00 | 6,566.58 |
|
Minority Interest
|
0.00 | 0.51 | 0.55 | 5.00 | 0.00 |
|
Non-Current Liabilities
|
7.59 | 47.15 | 5,213.99 | 1,617.00 | 557.10 |
|
Current Liabilities
|
297.11 | 253.37 | 5,158.51 | 1,785.00 | 1,747.98 |
|
Total Liabilities
|
1,328.74 | 1,983.96 | 17,723.32 | 8,578.00 | 7,682.91 |
Assets (₹ Cr)
| TTK Healthcare | Acutaas Chemicals | Piramal Pharma | Wockhardt | Granules India | |
|---|---|---|---|---|---|
|
Non-Current Assets
|
83.97 | 1,132.12 | 10,687.30 | 5,527.00 | 3,611.63 |
|
Current Assets
|
1,458.89 | 1,012.00 | 7,253.65 | 2,764.00 | 4,552.23 |
|
Total Assets
|
1,328.74 | 1,983.96 | 17,723.32 | 8,578.00 | 7,682.91 |
|
Total Debt*
|
21.90 | 26.49 | 5,495.48 | 2,125.00 | 1,338.13 |
|
Net Current Assets
|
1,161.78 | 758.64 | 2,095.14 | 979.00 | 2,804.25 |
|
Contingent Liabilities
|
16.76 | 17.25 | 95.72 | 768.26 | 0.93 |
Cashflow (₹ Cr)
| TTK Healthcare | Acutaas Chemicals | Piramal Pharma | Wockhardt | Granules India | |
|---|---|---|---|---|---|
|
Cash From Operating Activities
|
-21.15 | 292.17 | 1,652.60 | 390.00 | 793.25 |
|
Cash Flow from Investing Activities
|
51.58 | -265.94 | -826.03 | -241.00 | -773.21 |
|
Cash from Financing Activities
|
-17.56 | 4.10 | -38.98 | -54.00 | 379.29 |
|
Net Cash Inflow / Outflow
|
12.88 | 30.33 | 787.59 | 95.00 | 399.33 |
Ratios
Profitability Ratios
| TTK Healthcare | Acutaas Chemicals | Piramal Pharma | Wockhardt | Granules India | |
|---|---|---|---|---|---|
|
ROCE (%)
|
7.72 | 32.42 | 1.24 | 6.79 | 15.74 |
|
ROE (%)
|
5.94 | 25.02 | -2.55 | 7.91 | 12.04 |
|
ROA (%)
|
18.77 | 22.40 | -1.56 | 4.65 | 9.02 |
|
EBIT Margin (%)
|
3.05 | 36.50 | 3.19 | 14.37 | 17.27 |
|
Net Margin (%)
|
27.96 | 27.16 | -2.71 | 10.48 | 12.07 |
|
Cash Profit Margin (%)
|
0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Growth Ratios
| TTK Healthcare | Acutaas Chemicals | Piramal Pharma | Wockhardt | Granules India | |
|---|---|---|---|---|---|
|
Revenue Growth (%)
|
11.29 | 45.18 | 9.43 | 25.70 | 21.75 |
|
EBIT Growth (%)
|
47.06 | 115.51 | -3.72 | 139.56 | 36.34 |
|
Net Profit Growth (%)
|
317.32 | 95.80 | -199.34 | 894.12 | 39.13 |
|
EPS Growth (%)
|
3.49 | 63.29 | -410.28 | 599.72 | 32.20 |
|
Book Value Growth (%)
|
4.70 | 26.03 | 0.33 | 13.47 | 27.49 |
Valuation Ratios
| TTK Healthcare | Acutaas Chemicals | Piramal Pharma | Wockhardt | Granules India | |
|---|---|---|---|---|---|
|
Price / Earnings
|
17.67 | 72.46 | -153.46 | 76.96 | 29.52 |
|
Price / Book Value
|
0.96 | 17.13 | 3.92 | 6.11 | 4.56 |
|
Dividend Yield (%)
|
1.09 | 0.06 | 0.00 | 0.00 | 0.21 |
|
EV/EBITDA
|
18.55 | 50.74 | 30.04 | 42.00 | 17.02 |
|
Market Cap (₹ Cr)
|
1,046.57 | 20,944.75 | 18,108.89 | 19,071.62 | 15,391.88 |
Solvency Ratios
| TTK Healthcare | Acutaas Chemicals | Piramal Pharma | Wockhardt | Granules India | |
|---|---|---|---|---|---|
|
Debt to Equity
|
0.00 | 0.02 | 0.55 | 0.28 | 0.00 |
|
Short term debt to equity ratio
|
0.02 | 0.00 | 0.09 | 0.09 | 0.20 |
|
Current Ratio
|
4.91 | 3.99 | 1.41 | 1.55 | 2.60 |
|
Quick Ratio
|
4.53 | 2.89 | 0.77 | 1.00 | 1.54 |
|
Interest Coverage
|
140.62 | 143.52 | 0.89 | 3.04 | 10.17 |
Operating Efficiency Ratios
| TTK Healthcare | Acutaas Chemicals | Piramal Pharma | Wockhardt | Granules India | |
|---|---|---|---|---|---|
|
Debtors to sales (%)
|
12.75 | 22.50 | 23.05 | 16.85 | 16.05 |
|
Asset Turnover
|
0.62 | 0.81 | 0.56 | 0.43 | 0.75 |
|
Receivable days
|
41.32 | 88.98 | 78.20 | 58.75 | 33.72 |
|
Inventory Days
|
44.63 | 56.04 | 93.30 | 75.82 | 54.92 |
|
Payable days
|
89.62 | 99.95 | 226.14 | 186.21 | 136.11 |
|
Cash Conversion Cycle
|
-3.67 | 45.07 | -54.64 | -51.64 | -47.47 |
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
loading...
loading...
loading...
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.
